Literature DB >> 11575817

Is HCFA's reimbursement policy controlling quality of care for end-stage renal disease patients?

R S Lockridge1, J K McKinney.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11575817     DOI： 10.1097/00002480-200109000-00012

Source DB:  PubMed          Journal:  ASAIO J        ISSN： 1058-2916            Impact factor:   2.872


× No keyword cloud information.
  2 in total

1.  Technical breakthroughs in the wearable artificial kidney (WAK).

Authors:  Victor Gura; Alexandra S Macy; Masoud Beizai; Carlos Ezon; Thomas A Golper
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 8.237

2.  An economic assessment model for in-center, conventional home, and more frequent home hemodialysis.

Authors:  Paul Komenda; Meghan B Gavaghan; Susan S Garfield; Amy W Poret; Manish M Sood
Journal:  Kidney Int       Date:  2011-10-12       Impact factor: 10.612
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.